Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 111-120, 1 December 2006

Single voxel proton magnetic resonance spectroscopy in post-stroke depression

  • Lidia Glodzik-Sobanska

      Affiliations

    • Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 212 263 1091; fax: +1 212 263 3270.
  • ,
  • Agnieszka Slowik

      Affiliations

    • Department of Neurology, Institute of Neurology, Jagiellonian University, Krakow, Poland
  • ,
  • Pauline McHugh

      Affiliations

    • Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
  • ,
  • Barbara Sobiecka

      Affiliations

    • Department of Radiology, Jagiellonian University, Krakow, Poland
  • ,
  • Justyna Kozub

      Affiliations

    • Department of Radiology, Jagiellonian University, Krakow, Poland
  • ,
  • Kenneth E. Rich

      Affiliations

    • Center for Brain Health, New York University School of Medicine, New York, NY 10016, USA
  • ,
  • Andrzej Urbanik

      Affiliations

    • Department of Radiology, Jagiellonian University, Krakow, Poland
  • ,
  • Andrzej Szczudlik

      Affiliations

    • Department of Neurology, Institute of Neurology, Jagiellonian University, Krakow, Poland

Received 21 March 2006; received in revised form 6 July 2006; accepted 27 August 2006.

Abstract 

Mood disorders are associated with structural, metabolic and spectroscopic changes in prefrontal regions. In the case of depression associated with stroke, there is little information about the biochemical profile of these regions, as assessed by proton magnetic resonance spectroscopy (1H-MRS). In a group of first-ever stroke patients, we studied the association between post-stroke depression and 1H-MRS measurements in unaffected frontal lobes. Twenty-six patients with a first ischemic stroke located outside the frontal lobes were included in the study. Single voxel proton magnetic resonance spectroscopy (1H-MRS) was performed to assess N-acetylaspartate/creatine (NAA)/Cr, glutamate+glutamine (Glx)/Cr, choline (Cho)/Cr and myo-inositol (mI)/Cr ratios. Patients were assessed within the first 10 days after stroke and again four months later. The diagnosis of depression was made on the basis of clinical observation, interview and Hamilton Depression Rating Scale scores. In a group of 26 patients, eight (31%) met criteria for depression at the first assessment, and nine (35%) met criteria for depression at follow-up. Patients with depression in the immediate post-stroke phase had significantly higher Glx/Cr ratios in the contralesional hemisphere than non-depressive patients. No biochemical differences were found between the groups at 4-month follow-up. These findings suggest that post-stroke depression is accompanied by changes in frontal lobe glutamate/glutamine levels, perhaps reflecting abnormalities in glutamatergic transmission in the immediate post-stroke period.

Keywords: Magnetic resonance spectroscopy, Stroke, Mood disorders

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0925-4927(06)00128-4

doi:10.1016/j.pscychresns.2006.08.004

Psychiatry Research: Neuroimaging
Volume 148, Issue 2 , Pages 111-120, 1 December 2006